Analytical Cannabis recently spoke with Ananda’s Head of Plant Science, Dr. Nigel Gale, to learn more about this research and the advantages that a seed-based cultivation strategy could have for cultivators.
The Canadian cannabis regulator has recalled 1,632 pre-roll products because they were incorrectly labeled.
Adult-use, recreational cannabis became legally available in Missouri on Friday, February 3 – three days earlier than planned.
The CCB “has verified” that multiple samples of Holland Cannabis flower tested above the action limits for myclobutanil, a chemical used as a fungicide.
From July 1, psychiatrists in Australia will be allowed to prescribe MDMA and psilocybin as treatments for certain mental health conditions.
In the second of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
The change comes after the National Institute for Health and Care Excellence (NICE) issued final guidance recommending its use.
The Yale Center for the Science of Cannabis and Cannabinoids will foster studies into the acute and chronic effects of cannabinoids on neuronal and mental health.
Legalizing cannabis does not affect psychosis diagnoses or the prescription of antipsychotic medicines, a new study published in JAMA Network Open has found.
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.